BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 8396366)

  • 21. Measurement of cytokines by bioassays: theory and application.
    Meager A
    Methods; 2006 Apr; 38(4):237-52. PubMed ID: 16481200
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of a functional in vitro assay as a novel tool for the standardization of allergen extracts in the human system.
    Vogel L; Lüttkopf D; Hatahet L; Haustein D; Vieths S
    Allergy; 2005 Aug; 60(8):1021-8. PubMed ID: 15969682
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Desensitization and re-sensitization of CGRP receptor function in human neuroblastoma SK-N-MC cells.
    Pin SS; Xu C; Bahr BA
    Eur J Pharmacol; 2007 Dec; 577(1-3):7-16. PubMed ID: 17825280
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of an in vitro potency bioassay for therapeutic IL-13 antagonists: the A-549 cell bioassay.
    Miller R; Sadhukhan R; Wu C
    J Immunol Methods; 2008 May; 334(1-2):134-41. PubMed ID: 18355834
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The efficiency of calcitonin transport across the C-cell-blood barrier in rat thyroid.
    Krasnoperov RA; Grachev SV; Glumova VA; Gerasimov AN; Ryashchikov SN
    J Physiol Sci; 2006 Aug; 56(4):281-6. PubMed ID: 16875511
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the Vitotox and RadarScreen assays for the rapid assessment of genotoxicity in the early research phase of drug development.
    Westerink WM; Stevenson JC; Lauwers A; Griffioen G; Horbach GJ; Schoonen WG
    Mutat Res; 2009 May; 676(1-2):113-30. PubMed ID: 19393335
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative effects of diverse vertebrate gonadotropins on estradiol-17 beta formation in vitro in an immature rat Sertoli cell bioassay.
    Yu JY; Shen ST; Yang WH; Papkoff H; Ishii S
    Gen Comp Endocrinol; 1996 Nov; 104(2):253-61. PubMed ID: 8930616
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A sensitive human cell line based bioassay for megakaryocyte growth and development factor or thrombopoietin.
    Page LA; Thorpe R; Mire-Sluis AR
    Cytokine; 1996 Jan; 8(1):66-9. PubMed ID: 8742068
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of an edema factor-mediated cAMP-induction bioassay for detecting antibody-mediated neutralization of anthrax protective antigen.
    Zmuda JF; Zhang L; Richards T; Pham Q; Zukauskas D; Pierre JL; Laird MW; Askins J; Choi GH
    J Immunol Methods; 2005 Mar; 298(1-2):47-60. PubMed ID: 15847796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A lobster cysteine protease with immunoreactivity and activities of calcitonin and CGRP.
    Arlot-Bonnemains Y; Milhaud G; Fouchereau-Péron M
    C R Acad Sci III; 1996 Nov; 319(11):975-82. PubMed ID: 9033842
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening of some anti-androgenic endocrine disruptors using a recombinant cell-based in vitro bioassay.
    Roy P; Salminen H; Koskimies P; Simola J; Smeds A; Saukko P; Huhtaniemi IT
    J Steroid Biochem Mol Biol; 2004 Feb; 88(2):157-66. PubMed ID: 15084347
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Present status of calcitonin research with special attention to conditions in man].
    Sorensen OH; Hindberg I
    Ugeskr Laeger; 1970 Feb; 132(9):426-9. PubMed ID: 4914424
    [No Abstract]   [Full Text] [Related]  

  • 33. [New method of biological assay of calcitonin using miniature swine].
    Azria M; Kiger JL
    Therapie; 1974; 29(5):753-66. PubMed ID: 4462226
    [No Abstract]   [Full Text] [Related]  

  • 34. Unexpectedly high biological activity of synthetic human calcitonin.
    Tashjian AH; Voelkel EF
    J Clin Endocrinol Metab; 1970 Jul; 31(1):116-8. PubMed ID: 5425043
    [No Abstract]   [Full Text] [Related]  

  • 35. An improved method for the biological assay of thyrocalcitonin.
    Cooper CW; Hirsch PF; Toverud SU; Munson PL
    Endocrinology; 1967 Sep; 81(3):610-6. PubMed ID: 6033193
    [No Abstract]   [Full Text] [Related]  

  • 36. Tumour growth inhibition by calcitonin: role of the age of the animal and the hypocalcemic response.
    Anghileri LJ; Delbrück H; Cressent M; Pidoux E
    Arch Geschwulstforsch; 1980; 50(7):635-9. PubMed ID: 7235863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thyrocalcitonin: bioassay characteristics of purified preparations.
    Schlueter RJ; Aldred JP; Fisher JD
    Acta Endocrinol (Copenh); 1968 Jun; 58(2):268-76. PubMed ID: 5694744
    [No Abstract]   [Full Text] [Related]  

  • 38. Bioactivity-based screening of antibiotics and hormones.
    Bovee TF; Pikkemaat MG
    J Chromatogr A; 2009 Nov; 1216(46):8035-50. PubMed ID: 19342055
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blood pressure response associated with certain thyrocalcitonin preparations.
    Stahl PD; Waite LC; Kenny AD
    Endocrinology; 1967 Apr; 80(4):778-81. PubMed ID: 6022059
    [No Abstract]   [Full Text] [Related]  

  • 40. Human thyrocalcitonin.
    Haymovits A; Rosen JF
    Endocrinology; 1967 Nov; 81(5):993-1000. PubMed ID: 6052947
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.